Related Experiment Video

Updated: Jul 18, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells

Asish K Ghosh1, Robert Steele, Jan Ryerse

  • 1Department of Pathology and Cancer Center, Saint Louis University, St. Louis, Missouri 63104, USA.

Cancer Research
|December 21, 2006
PubMed

Insights

MBP-1 gene therapy significantly reduced non-small cell lung cancer (NSCLC) tumor growth and prolonged survival in mice. MBP-1 induced a novel necrosis-like cell death, offering a potential new treatment strategy for NSCLC.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Lung cancer, particularly non-small cell lung cancer (NSCLC), has a poor 5-year survival rate, necessitating novel therapeutic approaches.
  • Previous research demonstrated MBP-1's antiproliferative effects on various human cancer cells.
  • The urgent need for improved NSCLC treatments highlights the importance of exploring new therapeutic candidates.

Purpose of the Study:

  • To evaluate the potential of MBP-1 as a gene therapeutic agent for non-small cell lung cancer (NSCLC) regression.
  • To investigate the mechanism of cell death induced by MBP-1 in NSCLC cells.
  • To assess the efficacy of MBP-1 gene therapy in reducing tumor growth and improving survival in a preclinical NSCLC model.

Main Methods:

  • Exogenous expression of MBP-1 in H1299 NSCLC cells and human lung cancer xenografts in nude mice.
  • Intratumoral administration of replication-deficient recombinant adenovirus expressing MBP-1.
  • Analysis of cell death mechanisms, including poly(ADP-ribose) polymerase cleavage, caspase activity, plasma membrane permeability, mitochondrial damage, and cytoplasmic vacuolation.

Main Results:

  • Exogenous MBP-1 expression induced significant cell death in H1299 NSCLC cells.
  • Intratumoral MBP-1 gene therapy led to significant regression of lung tumor growth and prolonged survival in mice compared to control groups.
  • MBP-1 induced necrosis-like cell death characterized by early plasma membrane permeability and mitochondrial damage, without cytochrome c release, and was independent of caspase activation.

Conclusions:

  • MBP-1 gene therapy demonstrates significant potential as a novel therapeutic strategy for non-small cell lung cancer (NSCLC).
  • MBP-1 induces a unique form of necrosis-like cell death in NSCLC cells, offering a new avenue for cancer treatment.
  • Further investigation into MBP-1 as a gene therapeutic candidate for NSCLC is warranted based on these preclinical findings.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...